Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy
- 1 November 2017
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 38 (11) , 1006-1015
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- ATP Antagonizes Thrombin-Induced Signal Transduction through 12(S)-HETE and cAMPPLOS ONE, 2013
- 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivityThrombosis and Haemostasis, 2013
- The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathwaysBlood, 2012
- Protein Kinase C Regulation of 12-Lipoxygenase-Mediated Human Platelet ActivationMolecular Pharmacology, 2012
- Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic AcidJournal of Biological Chemistry, 2011
- Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12- LipoxygenaseJournal of Medicinal Chemistry, 2011
- Protease-Activated Receptor Signaling in Platelets Activates Cytosolic Phospholipase A2αDifferently for Cyclooxygenase-1 and 12-Lipoxygenase CatalysisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiencyBlood, 2010
- Phospholipid-esterified Eicosanoids Are Generated in Agonist-activated Human Platelets and Enhance Tissue Factor-dependent Thrombin GenerationJournal of Biological Chemistry, 2010
- Platelet Lipoxygenase DeficiencyNew England Journal of Medicine, 1977